ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,464.62
      -0.16%
      US Tech 100
      19,220.00
      -0.20%
      Dow Jones
      39,150.33
      0.04%
      Brent Oil
      84.39
      0.00%
      Bitcoin
      64,271.13
      0.29%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Vetoquinol (VETO) Quote

      Vetoquinol

      Vetoquinol (VETO)

      EU
      95.20
      -2.00
      (-2.06%)
      Closed June 22 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      95.20
      Bid
      95.20
      Ask
      92.90
      Volume
      3,999
      95.20 Day's Range 97.40
      76.30 52 Week Range 110.00
      Market Cap
      1.127B
      Previous Close
      97.20
      Open
      97.10
      Last Trade
      1
      @
      95.2
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      3,048
      Shares Outstanding
      11,834,162
      Dividend Yield
      0.89%
      PE Ratio
      20.28
      Earnings Per Share (EPS)
      4.69
      Revenue
      542.01M
      Net Profit
      55.56M

      About Vetoquinol

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.vetoquinol.com
      Headquarters
      Lure, Fra
      Founded
      1970
      Vetoquinol is listed in the Pharmaceutical Preparations sector of the Euronext with ticker VETO. The last closing price for Vetoquinol was 97.20 €. Over the last year, Vetoquinol shares have traded in a share price range of 76.30 € to 110.00 €.

      Vetoquinol currently has 11,834,162 shares outstanding. The market capitalization of Vetoquinol is 1.13 € billion. Vetoquinol has a price to earnings ratio (PE ratio) of 20.28.

      VETO Latest News

      More News

      VETOQUINOL : CHIFFRE D’AFFAIRES 1ER TRIMESTRE 2024 : 134 M€

      Regulatory News: Matthieu Frechin, Président-directeur général du laboratoire Vetoquinol (Paris:VETO), a déclaré : « Les bonnes performances dans la durée de nos deux axes stratégiques, les...

      April 29 2024
      Business Wire

      VETOQUINOL : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL (DEU) 2023

      Regulatory News: Vetoquinol (Parois:VETO) a déposé le 24 avril 2024 auprès de l’Autorité des marchés financiers (AMF) son Document d’enregistrement universel (DEU) 2023 au format ESEF (Format...

      April 24 2024
      Business Wire

      VETOQUINOL: RÉSULTATS ANNUELS 2023

      Regulatory News: Vetoquinol (Paris:VETO): Chiffre d’affaires annuel : 529 M€ (stable à changes constants) CA produits Essentiels : 313 M€ (+4,5 % à changes constants) Résultat net part du Groupe...

      March 20 2024
      Business Wire

      VETOQUINOL : CHIFFRE D’AFFAIRES ANNUEL 2023 : 529 M€

      CA produits Essentiels : 313 M€ (+4,5 % à changes constants) Regulatory News: Matthieu Frechin, Président-directeur général du laboratoire Vetoquinol (Paris:VETO), a déclaré : « Au sein d’un...

      January 24 2024
      Business Wire

      Vetoquinol: 2024 Calendar of Financial Communication

      Regulatory News: Vetoquinol (Paris:VETO) published its calendar of financial communication for 2024. January 24, 2024: 2023 Annual revenues (after market) March 20, 2024: 2023 Annual results...

      January 03 2024
      Business Wire

      Vetoquinol: Sales 3rd Quarter 2023

      Q3 Sales: €136m (+5.1% at constant exchange rates) Q3 Essentials Sales: €81m (+12.2% at constant exchange rates) Regulatory News: Matthieu Frechin, Chairman and CEO of Vetoquinol (Paris:VETO...

      October 26 2023
      Business Wire

      Vetoquinol : Communiqué de mise à disposition du Rapport financier semestriel au 30 juin 2023

      Regulatory News: Le laboratoire Vetoquinol (Paris:VETO) annonce ce jour avoir mis à disposition du public et déposé auprès de l’Autorité des marchés financiers son Rapport financier semestriel au...

      October 09 2023
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-5.8-5.7425742574310110295.2302097.28361589DE
      4-9.8-9.3333333333310510695.22564100.60539941DE
      12-4.6-4.6092184368799.810692.6304898.46046783DE
      26-5.6-5.55555555556100.811092.63016100.47111758DE
      525.76.368715083889.511076.3246795.00452428DE
      156-15.6-14.0794223827110.816176.33074110.08036954DE
      26037.865.853658536657.416141.9291596.59611676DE

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AREBAmerican Rebel Holdings Inc
      $ 0.76
      (152.49%)
      		371.46M
      SHCRSharecare Inc
      $ 1.365
      (76.27%)
      		56.33M
      NXLNexalin Technologies Inc
      $ 1.7499
      (59.08%)
      		57.58M
      FUFUBitFuFu Inc
      $ 6.1209
      (56.95%)
      		2.5M
      SPECSpectaire Holdings Inc
      $ 0.50
      (47.06%)
      		65.27M
      FLFVFeutune Light Acquisition Corporation
      $ 2.5502
      (-69.75%)
      		862.38k
      FLFVUFeutune Light Acquisition Corporation
      $ 2.75
      (-66.83%)
      		16.5k
      RWODRedwoods Acquisition Corporation
      $ 2.34
      (-60.34%)
      		155.96k
      KAVLKaival Brands Innovations Group Inc
      $ 1.23
      (-57.14%)
      		4.92M
      RWODURedwoods Acquisition Corporation
      $ 3.24
      (-56.28%)
      		1.47k
      NVDANVIDIA Corporation
      $ 126.57
      (-3.22%)
      		658.13M
      AREBAmerican Rebel Holdings Inc
      $ 0.76
      (152.49%)
      		371.46M
      SIRISirius XM Holdings Inc
      $ 2.94
      (1.38%)
      		330.66M
      AAPLApple Inc
      $ 207.49
      (-1.04%)
      		246.38M
      NKLANikola Corporation
      $ 0.3466
      (5.16%)
      		193.36M

      Discussion

      View Full Feed
      misterfishman misterfishman 2 minutes ago
      I hope we see .01 at least on monday.
      IGPK
      dukeb dukeb 4 minutes ago
      So Greg Abbott was serious when he said they would eliminate rape in the State of Texas?

      In Texas they are arresting pastors in droves today for molesting children.
      misterfishman misterfishman 6 minutes ago
      Looking foward to that blue sky breakout and ill be watching myself on this board from now on see you later bro.
      RONN
      theorysuit theorysuit 6 minutes ago
      Why can't he question what the plan to commercialization including funding? You pumpers are all the same. If you question management kn any way, it is all fud and just stfu and sell. Please you should stop investing right now. I didn't know this message board was just pro propoganda for NWB
      NWBO
      dukeb dukeb 7 minutes ago
      Any of the hardcore religions (throw the radical Moslems, the Hassidic Jews and others into the mix) seem to have lots in common. Maybe not on the specifics, but the dogma and need to control so many aspects of people's lives. Well, women in particular.

      People who are super religiou
      sab63090 sab63090 7 minutes ago
      Not necessarily corrupt, but beholden to Big Pharma $$$....please explain why several resigned over that $BIIB approval and the EMA would not approve
      BIIB
      JamesF1 JamesF1 8 minutes ago
      I definitely agree this is good news. I don’t understand why Nostrum never commercialized the products after buying them. These are meds that sell everyday in every pharmacy.
      ELTP
      MrSmithLWLG MrSmithLWLG 8 minutes ago
      Good post!

      It’s a risk factor for me at this point. 12 months ago I thought the risk was dramatically reduced, after the European and US investor meetings, risk went from 4 to 8.5 for me (1 no risk - 10 wholly shot risk).
      LWLG
      sharkey1 sharkey1 8 minutes ago
      It’s a long weekend till Mon. 9:30 am.
      Can’t wait for the press release, it should include
      the opening of the new plant too.
      And looks like they will need to hire more people
      for the second shift.
      ELTP
      StevenDice StevenDice 10 minutes ago
      Given how Lebby evaded answering your questions at the ASM, and has wantonly misrepresented and obfuscated the company’s progress and technical hurdles; how can you give any credibility whatsoever to their claims?

      Everything tedpeele states may not be perfectly accurate, however, his
      ASM
      Jasbg Jasbg 13 minutes ago
      ProLiberty, Agreed in headlines of your constructive thinking.

      What we all have to remember is that Sarissa is a very experienced HF - that is in every way in known terrority with undervalued Bio company Amarin - which is exactly what Denner have specialized in.

      As yo
      AMRN
      gdog gdog 13 minutes ago
      Take it easy Boss.

      NLST get some
      NLST
      ksquared ksquared 19 minutes ago
      Since Mr. Trump’s temperament has drawn the most intense objurgation from his detractors, the easiest thing he can do in this debate is just mind his manners, and not allow himself to be baited or taunted. I hope President Trump heeds Kunstler's advice... if the debate takes place. ... do
      dukeb dukeb 19 minutes ago
      I wouldn't go so far as to say that OF is sinister, just not something you would probably be interested in as a streamer or a viewer.

      Lots of people seem to make a living by performing on OF. I'm not in a position to judge.

      I am aware that Only Fans is sinister.
      TRIPLE_ZERO_SEVEN TRIPLE_ZERO_SEVEN 22 minutes ago
      Ha, Ha! Yea. Thought that was funny too.
      AAPJ
      LetGoodTimesRoll LetGoodTimesRoll 25 minutes ago
      $RNVA =====>KABOOM BOOM BOOM diggity$$$$$$
      RNVA
      Wise Man Wise Man 26 minutes ago
      Addressed to low-income families, ST conceals the 9.5% rate.
      Obscurantism.
      FNMA
      HGilS HGilS 29 minutes ago
      Can’t sleep lol
      ELTP
      StonkMaster StonkMaster 32 minutes ago
      When they issued that statement, they were referring to the validation of the MAA: the time between January 24th and March 7th in which the MHRA needed to "confirm" the validation.

      They were not implying that no RFI had or will be requested. Contact the company and ask for yourself.
      NWBO
      Seminole Red Seminole Red 34 minutes ago
      anticipation ....
      Wise Man Wise Man 36 minutes ago
      Subsection (c) any obligations of subsection (b) REDEEMABLE OBLIGATIONS.
      More evidence that this hybrid financial instrument could have been purchased through subsection (c), either as a Preferred Stock and as its underlying security, an obligation (fixed-income security), because all the Pre
      FNMA
      PonkenPlonken PonkenPlonken 37 minutes ago
      just give it some time prior to the PDUFA. I dont have a position and i dont need to play.
      Id only buy some if there is strength....
      ADAP
      #1 PATRIOTS_RSOX FAN #1 PATRIOTS_RSOX FAN 37 minutes ago
      Dilution Dilution and more Dilution. WoW what a ticker.

      SFLM=Dilution King
      SFLM
      Seminole Red Seminole Red 37 minutes ago
      I did that with a boat at the dock when i was 8,,,,should have never untied it, drifted way out in the Intercoastal. no paddle, no motor and its leaking. Lucky some fishermen saw me an towed me back in.....Got in a lotta trouble for that
      fuagf fuagf 41 minutes ago
      A food story of a great migrant - Chef Boyardee is an American brand of canned pasta products sold internationally by Conagra Brands. The company was founded by Italian immigrant Ettore Boiardi in Milton, Pennsylvania, U.S., in 1928.[1][2]

      History

      The Chef Boyardee fact

      Your Recent History

      EU
      VETO
      Vetoquinol
      EU
      GB00B73ZYW09
      Royal Bank of Scotland
      COIN
      HSRKRW
      Hcash
      NASDAQ
      FRGAP
      Franchise
      Delayed Upgrade Clock